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Purpose: To report a case of acute placoid multifocal posterior pigment epitheliopathy (APMPPE)
following inﬂuenza vaccination. The patient exhibited granulomatous uveitis during the recovery phase.
Observations: A woman in her thirties developed ﬂu-like symptoms seven days after receiving an
inﬂuenza vaccination. Approximately 2 weeks later, the patient reported with conjunctival injection,
blurred vision, and pain in her left eye. She was examined in our clinic, and the best-corrected visual
acuity was 20/15 OD and 20/20 OS. Multiple whitish spots were observed bilaterally in the deep retinal
layer along with edema of the left optic disc. Both indocyanine green and ﬂuorescein angiographic
ﬁndings suggested a diagnosis of APMPPE. Although APMPPE lesions were gradually resolved after one
month, keratic precipitates, anterior chamber and vitreous cellular inﬁltration, iris and angle nodules,
and macular edema were observed and were treated with topical steroid eye drops. No systemic dis-
orders including sarcoidosis, tuberculosis, and Wegener's granulomatosis were present.
Conclusion and importance: As inﬂuenza vaccinations are administered worldwide, ophthalmologists
should be aware of the ocular side effects following vaccination. Although rare, the possibility of APMPPE
occurrence following inﬂuenza vaccination should be considered; additionally, the recovery phase of
APMPPE may be associated with granulomatous uveitis that requires steroid therapy.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Acute posterior multifocal placoid pigment epitheliopathy
(APMPPE) was ﬁrst reported in a study by Gass;1 it mostly exhibits a
self-limited benign clinical course. Its precise pathogenesis has not
been described. Although it usually occurs in otherwise healthy
young adults, it may occur in association with severe systemic
disorders, including tuberculosis,2 Wegener's granulomatosis,3 ce-
rebral vasculitis,4 Lyme disease,5 and sarcoidosis.6 In addition, it
rarely occurs following vaccination for hepatitis B virus,7 menin-
gococcus C,8 varicella zoster virus,9 and inﬂuenza virus.10
To our knowledge, only one case of APMPPE following human
inﬂuenza virus vaccine was reported,10 and this case reportedly
demonstrated a benign clinical course. Accordingly, we report the
ﬁrst case of APMPPE following inﬂuenza vaccination that later
developed into granulomatous uveitis.zawa).
Inc. This is an open access article u2. Case report
A woman in her thirties developed ﬂu-like symptoms including
fever, cough, and nausea 7 days after a subcutaneous administra-
tion of inﬂuenza vaccine. Approximately 10 days after the onset of
initial symptoms, the patient noticed redness and blurred vision in
her left eye. Three days later, she developed pain in the same eye. As
these symptoms did not resolve, she consulted an ophthalmologist.
Following a clinical examination, the best-corrected visual acuity
(BCVA) was 20/15 OD and 20/20 OS. The intraocular pressure was
19 mmHg OD and 15 mmHg OS. The slit-lamp biomicroscopic ex-
amination revealed cellular inﬁltration (1 þ cell) in the left anterior
chamber, and the fundus examination revealed optic disc edema in
the same eye. The patient was treated with systemic and topical
non-steroid anti-inﬂammatory drugs (NSAIDs). For the observed
signs of uveitis, she was referred to the Department of Ophthal-
mology at Hirosaki University Hospital on the following day. On
examination, it was observed that the ocular injection had resolved,
and the BCVAwas 20/15 OD and 20/20 OS. The intraocular pressure
was 14 mmHg OD and 11 mmHg OS. Although there were nonder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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fundus examination revealed multiple whitish spots present
bilaterally in the deep layer of the retina along with optic disc
edema in the left fundus (Fig. 1A and B). The indocyanine green
angiography (IA) exhibited multiple hypoﬂuorescent spots bilat-
erally (Fig. 1C). Fluorescein angiography (FA) initially showed
bilateral presence of hypoﬂuorescent spots that gradually turned
hyperﬂuorescent. Extensive ﬂuorescent dye leakage from the left
optic disc was observed (Fig.1D). Laboratory examinations revealed
that the blood cell counts, kidney function, liver function, and
serum electrolyte levels were within the normal range. The C-
reactive protein level was less than 0.020 mg/dl, angiotensin-
converting enzyme level was 15.2 U/l, soluble IL-2 receptor level
was 156 U/l, and CD4/8 ratio was 2.92. Tests for serologic anti-
nuclear antigens were negative. Although the patient tested posi-
tive for cutaneous tuberculin reaction, the T-spot test showed
negative results. No acute elevation of anti-viral antibodies against
varicella zoster virus, herpes simplex virus, EB virus, and cyto-
megalovirus were observed. Since these ﬁndings suggested a
diagnosis of APMPPE, we decided to carefully observe the patient
following continued treatment with topical bromofenac sodium
hydrate eye drops only. Systemic NSAID treatment was dis-
continued. One month after the initial examination, although the
BCVA was 20/15 OD and 20/20 OS, ﬁne keratic precipitates were
observed and cells (1 þ cell) were detected bilaterally in both the
anterior chamber and anterior vitreous space. In addition, there
were bilateral iris and angle nodules (Fig. 2A). Since these ﬁndings
suggested a diagnosis of granulomatous uveitis, bromofenacFig. 1. Fundus images of a patient with acute posterior multifocal placoid pigment epitheliop
the left eye (A). At the initial examination, optical coherence tomography at the horizontal
associated with optic disc edema and swelling of retinal pigment epithelium corresponding
show multiple hypoﬂuorescent spots exhibited bilaterally (C). Fluorescein angiography ﬁnd
into hypoﬂuorescent spots in the late phase, and ﬂuorescein dye leakage from the left optic d
referred to the web version of this article.)sodium treatment was discontinued and treatment with 0.1% ﬂu-
orometholone eye drops was started. Twoweeks later, although the
bilateral keratic precipitates, anterior chamber cells (1 þ cell), and
left optic disc edema were still present, the iris and angle nodules
disappeared. However, there was macular edema in the left eye
(Fig. 2B). The BCVA was 20/15 OD and 20/25 OS. Treatment with
0.1% ﬂuorometholone was replaced with 0.1% betamethasone eye
drops. In order to evaluate the possibility of presence of sarcoidosis
or other systemic disorders, the patient was further referred to
internists. Chest radiography and CT ﬁndings did not exhibit
bilateral hilar lymphadenopathy and alveolar biopsy and bron-
choalveolar cytological examination did not detect any evidence of
pathologic lesions, including those of sarcoidosis and tuberculosis.
Electrocardiography showed normal ﬁndings. No other systemic
signs suggestive of sarcoidosis and other systemic disorders,
including tuberculosis, Lyme disease, Wegener's granulomatosis
and other cerebral diseases were observed. The fundus lesions
gradually disappeared after another month (Fig. 2C and D). The
ﬁnal BCVA was 20/15 OU.3. Discussion
Inﬂuenza vaccination is performed worldwide and is especially
recommended for older people and/or people with chronic dis-
eases. Therefore, ophthalmologists should be aware of the ocular
side effects of inﬂuenza vaccine as well as other vaccines. In addi-
tion, as this vaccination is required for health care providers and
associated personnel, they might also be at risk. Although ocularathy. Multiple whitish spots are observed bilaterally and optic disc edema is present in
section indicated in the fundus image (a yellow line in A) demonstrates retinal edema
to a whitish spot in the left eye (arrow) (B). Indocyanine green angiography ﬁndings
ings show bilaterally present hyperﬂuorescent spots in the early phase, development
isc (D). (For interpretation of the references to colour in this ﬁgure legend, the reader is
Fig. 2. Anterior segment and gonioscopic photographies of a patient with acute posterior multifocal placoid pigment epitheliopathy. The anterior segment photograph (left) of the
left eye reveals multiple iris nodules (arrows), and the gonioscopic photograph (right) demonstrates iris (arrow) and angle (arrowhead) nodules (A). Six weeks after the initial
examination, optical coherence tomography of the left eye at the horizontal section (same as Fig. 1B) demonstrates macular edema (B). One month later, optical coherence to-
mography of the left eye at the same section as Fig. 2B shows resolution of macular edema after treatment (C). Additionally, a fundus photograph obtained one month later shows
that the lesions gradually resolved after a topical steroid treatment (D).
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orbital myositis, posterior scleritis, optic neuritis, uveitis, oculo-
respiratory syndrome, and APMPPE have been previously
reported.10e13 Although we presented a report on the second case
of APMPPE following human inﬂuenza vaccination, the patient later
developed granulomatous uveitis while undergoing treatment for
APMPPE with topical non-steroid anti-inﬂammatory eye drops. It
was not possible to infer if the observed granulomatous uveitis was
a side effect of the inﬂuenza vaccine, and if APMPPE, like ocular
sarcoidosis,6 was an antecedent sign of granulomatous uveitis.
Further studies are needed to verify these associations. However,
we should take into consideration that APMPPE can develop
following inﬂuenza vaccination, and that it can later be associated
with granulomatous uveitis that requires steroid therapy. Although
APMPPE is known to be a self-limited, benign clinical entity, careful
follow-up should be considered even after the resolution of fundus
ﬁndings to avoid undetected delayed onset inﬂammation affecting
other parts of the eye that would require treatment, or the devel-
opment of an associated systemic disorder.
4. Patient consent
This case report was ethically approved by the Institutional
Review Board and written consent to publish the report was ob-
tained from the patient.Acknowledgment
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